Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Study to Evaluate ITCA 650 Compared to Sitagliptin as add-on Therapy for the Treatment of Type 2 Diabetes

ClinicalTrials.gov ID: NCT01455870

Public ClinicalTrials.gov record NCT01455870. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 6:08 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Active Comparator, Double-Blind, Multi-Center Study to Compare the Efficacy, Safety and Tolerability of ITCA 650 to Sitagliptin as Add-on Therapy to Metformin in Patients With Type 2 Diabetes

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Phase 3 study to compare treatment with ITCA 650 to sitagliptin when added to metformin monotherapy in patients with type 2 diabetes.

Study identification

NCT ID
NCT01455870
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Intarcia Therapeutics
Industry
Enrollment
535 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 2013 (Type not available)
Primary completion
Jul 2015 (Actual)
Completion
Jul 2015 (Actual)
Last update posted
Jun 2, 2016

2013 – 2015

United States locations

U.S. sites
50
U.S. states
23
U.S. cities
47
Facility City State ZIP Site status
Not listed Birmingham Alabama 35235 —
Not listed Chandler Arizona 85224 —
Not listed Long Beach California 90807 —
Not listed Los Angeles California 90017 —
Not listed San Diego California 92101 —
Not listed San Mateo California 94401 —
Not listed Tustin California 92780 —
Not listed Valley Village California 91607 —
Not listed Walnut Creek California 94598 —
Not listed Boca Raton Florida 33432 —
Not listed Clearwater Florida 33765 —
Not listed Coral Gables Florida 33134 —
Not listed Miami Florida 33126 —
Not listed North Miami Beach Florida 33162 —
Not listed Pembroke Pines Florida 33026 —
Not listed Canton Georgia 30114 —
Not listed Chicago Illinois 60607 —
Not listed Chicago Illinois 60634 —
Not listed Avon Indiana 46123 —
Not listed Franklin Indiana 46131 —
Not listed Greenfield Indiana 46140 —
Not listed Muncie Indiana 47304 —
Not listed Valparaiso Indiana 46383 —
Not listed Wichita Kansas 67205 —
Not listed Wichita Kansas 67208 —
Not listed Metairie Louisiana 70006 —
Not listed Brockton Massachusetts 2301 —
Not listed Traverse City Michigan 49684 —
Not listed Troy Michigan 48098 —
Not listed St Louis Missouri 63110 —
Not listed Billings Montana 59101 —
Not listed Lincoln Nebraska 68510 —
Not listed Las Vegas Nevada 89148 —
Not listed Brooklyn New York 11218 —
Not listed Endwell New York 13760 —
Not listed Morehead City North Carolina 28557 —
Not listed Winston-Salem North Carolina 27103 —
Not listed Cincinnati Ohio 45227 —
Not listed Kettering Ohio 45429 —
Not listed Norman Oklahoma 73069 —
Not listed Bend Oregon 97701 —
Not listed Uniontown Pennsylvania 15401 —
Not listed Memphis Tennessee 38119 —
Not listed Corpus Christi Texas 78414 —
Not listed Dallas Texas 75230 —
Not listed Dallas Texas 75390 —
Not listed Houston Texas 77083 —
Not listed San Antonio Texas 78229 —
Not listed Sugar Land Texas 77478 —
Not listed Tomball Texas 77375 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01455870, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 2, 2016 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01455870 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →